COVID-19 vaccine boosters: What do we know so far?

Affiliations

• ¹ AP-HP, Bichat University Hospital, DMU INVICTUS, Infectious Diseases Department, Paris, France.
• ² Paris-Saclay University, UVSQ, INSERM, Gustave Roussy, "Exposome and Heredity" Team, CESP UMR1018, Villejuif, France.
• ³ AP-HP, Bichat University Hospital, DMU PARABOL, Department of Anaesthesiology and Critical Care, Paris, France; Paris University, Paris, France.
• ⁴ Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France; CHU Caen, Department of Anaesthesiology and Critical Care Medicine, Caen University Hospital, Avenue de la Côte de Nacre, Caen, France.
• ⁵ AP-HP, Bichat University Hospital, DMU INVICTUS, Infectious Diseases Department, Paris, France; INSERM, IAME, Paris University, Paris, F-75006, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK. Electronic address: nathan.peiffer-smadja@aphp.fr.